A patent portfolio has never closed a round. I want to state that plainly, because the prevailing advice in physical AI right now treats filings as a fundraising instrument, and that framing gets the causality backwards. Investors are not buying your claims. They are buying evidence that you understand your own system well enough to describe where it is hard to copy. The patent is a byproduct of that understanding, not a substitute for it.
This distinction matters more in 2026 than it did two years ago. Venture funding for physical AI surged this year, and the surge itself changes what a filing signals. When capital is scarce, a patent family reads as differentiation. When capital is abundant and dozens of teams are shipping manipulation stacks, mobile bases, and sim-to-real pipelines, a filing reads as table stakes at best and as noise at worst. Abundance inflates the denominator. Everyone files. The signal decays.
What Broad Claims Actually Communicate
One industry analysis put it bluntly: broad AI patents, the kind written over neural networks generally, are now seen as too late and too broad. I would go further. A broad claim in this space is an admission, not an asset. It tells a technically literate reader that the filer could not identify a specific, non-obvious mechanism in their own stack worth protecting, so they reached for generality instead.
Consider what actually makes a physical AI system hard to replicate. It is rarely the architecture. Transformer-based policies, diffusion policies, and visuomotor encoders are published, reproduced, and re-implemented within months. The difficulty sits somewhere less glamorous:
- Calibration and state estimation under drift, where a specific correction procedure keeps a manipulator accurate across thousands of hours
- Data collection and labeling loops that convert teleoperation sessions into training signal without human bottlenecks
- Failure detection and recovery behaviors, including how a system decides it is uncertain enough to stop
- The control interface between a learned policy and a deterministic safety layer, which is where most real deployments actually live or die
These are narrow, unglamorous, and genuinely defensible. They are also where value has migrated, according to the same analysis. A claim written at this level is legible to an engineer reading it during diligence. It says: we have run this system long enough in the world to know which specific thing breaks, and we solved it in a way that is not obvious.
The Timing Argument Is the Strong One
Foley & Lardner’s read on the generative AI patent wave is that it is being seeded now, and that physical AI companies should position before it arrives. I think this is the most defensible reason to file aggressively, and it has nothing to do with fundraising narrative. It is about prior art density.
Patentability in a field degrades over time as the published record thickens. Every paper, every filing, every product disclosure narrows the space of what remains non-obvious. Physical AI is currently in the window where embodied-specific mechanisms are still sparsely covered relative to how quickly the field is moving. That window closes on its own schedule, indifferent to your funding timeline. Filing now is a hedge against a future in which the same mechanism is unpatentable because forty teams described adjacent versions of it first.
That is a real argument. It is just not a pitch-deck argument.
How Patents Actually Function in Diligence
In my experience reading technical diligence materials, filings do three useful things, none of which is persuasion:
First, they create a structured record of what the team believes is novel. A specification is a forced exercise in precision. Vague teams write vague specifications, and that shows.
Second, they reduce perceived downside for later-stage capital. An acquirer or a Series C investor wants to know that a larger competitor cannot ship the same capability without friction. Patents do not prevent this, but they raise cost and create use in negotiation.
Third, they establish cadence as a proxy for engineering velocity, but only when the filings track shipped capability. Patent cadence is part of the fundraising story when it maps to defensible shipped technology. When it maps to nothing shipped, cadence reads as legal spend, and sophisticated investors discount it accordingly.
The Order of Operations
The teams getting this right are not filing to raise. They are building systems that work in physical environments, noticing which specific mechanisms make those systems work, and filing on those mechanisms because the timing window favors it. The fundraising benefit arrives as a consequence.
The teams getting it wrong are filing broadly and early, hoping the portfolio will substitute for deployment evidence. It will not. A patent describes what you claim to have invented. A running system describes what you actually built. In physical AI, where the gap between simulation and reality is the entire problem, investors have learned to tell the difference.
File early, file narrow, file on what you have shipped. Then let the system do the convincing.
🕒 Published: